West Pharmaceutical Services (WST)
Stock-Based Compensation
$10.90M
Quarterly · Period ending: · USD
WST Stock-Based Compensation
Latest reported$10.90Mperiod ending
Latest reported$10.90Mperiod ending
WST Quarterly Stock-Based Comp ($0.00 → $10.90M)
Quarterly stock-based compensation
High-resolution chart · PNG
WST stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 10,900,000 | |
| 6,600,000 | |
| 6,700,000 | |
| 8,400,000 | |
| 7,400,000 | |
| 1,300,000 | |
| 4,300,000 | |
| 5,100,000 | |
| 4,300,000 | |
| 5,000,000 | |
| 1,400,000 | |
| 5,900,000 | |
| 7,500,000 | |
| 8,500,000 | |
| 6,700,000 | |
| 6,000,000 | |
| 5,500,000 | |
| 5,500,000 | |
| 10,000,000 | |
| 11,300,000 | |
| 10,300,000 | |
| 5,900,000 | |
| 6,400,000 | |
| 9,900,000 | |
| 12,300,000 | |
| 5,400,000 | |
| 5,600,000 | |
| 5,400,000 | |
| 7,200,000 | |
| 6,200,000 | |
| 400,000 | |
| 5,300,000 | |
| 6,000,000 | |
| 3,400,000 | |
| 2,500,000 | |
| 4,600,000 | |
| 5,500,000 | |
| 3,500,000 | |
| 5,400,000 | |
| 4,600,000 | |
| 4,900,000 | |
| 4,600,000 | |
| 5,200,000 | |
| 3,600,000 | |
| 15,500,000 | |
| 5,300,000 | |
| 6,100,000 | |
| 3,600,000 | |
| 4,600,000 | |
| 4,300,000 | |
| 5,600,000 | |
| 5,200,000 | |
| 5,000,000 | |
| 5,400,000 | |
| 3,700,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -1,600,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |